[Epidemiology and climate and geographic risk factors of stroke in the South Kazakhstan region].

Stroke is a most frequent life threatening neurological disease and one of the most important causes of disability in Kazakhstan as well as in the whole world. Among CIS, the Kazakh Republic holds the second place after Moldova in mortality from cardiovascular diseases. Some researchers assume that official statistical data do not reflect completely the state of the problem in Kazakhstan due to the lack of representative population epidemiological studies.

[Clinical efficiency of Vasonat in neurometabolic therapy of patients with ischemic stroke at early rehabilitation period].

Research of efficiency and safety of Vasonat has been carried out. 31 patients aged 46-75 years who had had hemispheric athero- thrombotic or hemodynamic schemic stroke with moderate severity and being treated in 2-5-month of early rehabilitation period have been observed. The control group of patients received placebo.